Insider's recent share sale at current price is viewed negatively. Absence of insider purchases and history of sales over the past year raises caution for potential investors. Despite insider ownership, alignment with other shareholders is weak.
Rising insider sales at Silk Road Medical and no insider purchases in past year suggest potential dip in stock performance. Also, low insider ownership suggests less motivation for long-term company growth.
Upgrades •$Banc of California(BANC.US)$: Raymond James Upgrades to Outperform from Market Perform - PT $22 •$庫倫佛寺銀行(CFR.US)$: Raymond James Upgrades to Outperform from Market Perform •$美國固安捷(GWW.US)$: Wolfe Research Upgrades to Outperform from Peerperform •$Invitation Homes(INVH.US)$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44) •$PCB Bancorp(PCB.US)$: Raymond James Upgrades to Outperform from Market Perfor...
Silk Road Medical股票討論區
In reaction to earnings/guidance:
• $梯瓦製藥(TEVA.US)$ +24%(also announces agreement for opioids settlement), $Enphase Energy(ENPH.US)$ +9.5%, $Spotify Technology(SPOT.US)$ +9.2%, $RPC Inc(RES.US)$ +8.5%, $奇波雷墨西哥燒烤(CMG.US)$ +8.2%, $Manhattan Associates(MANH.US)$ +8.1%, $希爾頓酒店(HLT.US)$ +6.7%, $ChampionX(CHX.US)$ +6.1%, $Mr. Cooper Group(COOP.US)$ +5.7%, $Constellium(CSTM.US)$ +5.5%, $波士頓科學(BSX.US)$ +5.4%,...
• $Repare Therapeutics(RPTX.US)$ +26.4% (announces worldwide license and collaboration agreement with Roche for camonsertib)
• $Chewy(CHWY.US)$+19.8% (Chewy stock soars on earnings. Here's what really mattered)
• $UiPath(PATH.US)$ +11.7% ( reported first-quarter revenue growth of 32% year-over-year to $245.1 million)
• $Pure Storage(PSTG.US)$ +10.6% (In reaction to earnings)
• $Credo Technology(CRDO.US)$ +10.2% (In reaction ...
• $Banc of California(BANC.US)$: Raymond James Upgrades to Outperform from Market Perform - PT $22
• $庫倫佛寺銀行(CFR.US)$: Raymond James Upgrades to Outperform from Market Perform
• $美國固安捷(GWW.US)$: Wolfe Research Upgrades to Outperform from Peerperform
• $Invitation Homes(INVH.US)$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $PCB Bancorp(PCB.US)$: Raymond James Upgrades to Outperform from Market Perfor...
暫無評論